Showing 1 - 20 results of 103 for search 'Mengtao Li', query time: 0.07s Refine Results
  1. 1
    LSO-026 Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: results from a real-world CSTAR cohort study

    LSO-026 Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: results from a real-world CSTAR cohort study by Wei Bai, Mengtao Li

    Published 2023-07-01
    Article
  2. 2
    New insights into the pathogenesis and management of rheumatoid arthritis

    New insights into the pathogenesis and management of rheumatoid arthritis by Shangyi Jin, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis

    Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis by Siyuan Fan, Jiuliang Zhao, Jiuliang Zhao, Jiuliang Zhao, Jiuliang Zhao, Bo Hou, Mange Liu, Jingwen Niu, Yan Zhou, Chenhui Mao, Haitao Ren, Feng Feng, Mengtao Li, Mengtao Li, Mengtao Li, Mengtao Li, Xiaofeng Zeng, Xiaofeng Zeng, Xiaofeng Zeng, Xiaofeng Zeng, Yicheng Zhu, Hongzhi Guan

    Published 2023-06-01
    Get full text
    Article
  4. 4
    Applications of Next-generation Sequencing in Systemic Autoimmune Diseases

    Applications of Next-generation Sequencing in Systemic Autoimmune Diseases by Yiyangzi Ma, Na Shi, Mengtao Li, Fei Chen, Haitao Niu

    Published 2015-08-01
    Get full text
    Article
  5. 5
    The impact and outcomes of cancer-macrophage fusion

    The impact and outcomes of cancer-macrophage fusion by Mengtao Li, John R. Basile, Sanjay Mallya, Yi-Ling Lin

    Published 2023-06-01
    Get full text
    Article
  6. 6
    Structural and Functional Characterization of Gray Matter Alterations in Female Patients With Neuropsychiatric Systemic Lupus

    Structural and Functional Characterization of Gray Matter Alterations in Female Patients With Neuropsychiatric Systemic Lupus by Li Su, Li Su, Li Su, Zhizheng Zhuo, Yunyun Duan, Jing Huang, Xiaolu Qiu, Mengtao Li, Mengtao Li, Yaou Liu, Xiaofeng Zeng, Xiaofeng Zeng

    Published 2022-05-01
    Get full text
    Article
  7. 7
    Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study

    Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study by Yu Shi, Hui Jiang, Yongqiang Zhao, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng

    Published 2023-02-01
    Get full text
    Article
  8. 8
    Identification of potential susceptibility genes in patients with primary Sjögren’s syndrome-associated pulmonary arterial hypertension through whole exome sequencing

    Identification of potential susceptibility genes in patients with primary Sjögren’s syndrome-associated pulmonary arterial hypertension through whole exome sequencing by Mucong Li, Yue Shi, Jiuliang Zhao, Qian Wang, Mengtao Li, Xiuli Zhao

    Published 2023-09-01
    Get full text
    Article
  9. 9
    LSO-073 Improvements and challenges of systemic lupus erythematosus associated pulmonary arterial hypertension: a 10-year multicenter cohort study

    LSO-073 Improvements and challenges of systemic lupus erythematosus associated pulmonary arterial hypertension: a 10-year multicenter cohort study by Xiaofeng Zeng, Qian Wang, Jiuliang Zhao, Mengtao Li, Junyan Qian, Xingbei Dong

    Published 2023-07-01
    Article
  10. 10
    Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis

    Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis by Shuo Zhang, Ziyue Zhou, Li Wang, Mengtao Li, Fengchun Zhang, Xiaofeng Zeng

    Published 2021-02-01
    Get full text
    Article
  11. 11
    Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China

    Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China by Shasha Hu, Yong Hou, Qian Wang, Mengtao Li, Dong Xu, Xiaofeng Zeng

    Published 2018-10-01
    Get full text
    Article
  12. 12
    Immunoglobulin G4-Related Disease Accompanied by Primary Myelofibrosis: Case Report

    Immunoglobulin G4-Related Disease Accompanied by Primary Myelofibrosis: Case Report by Ziwei Liu, Shangzhu Zhang, Wen Zhang, Jun Feng, Mengtao Li, Xiaofeng Zeng

    Published 2021-05-01
    Get full text
    Article
  13. 13
    High flashover strength and superhydrophobic coatings by constructing porous surface structure

    High flashover strength and superhydrophobic coatings by constructing porous surface structure by Mengtao Li, Tingxin Chen, Xiaobo Guo, Lei Dong, Jiming Chen, Mingxiao Zhu

    Published 2023-08-01
    Get full text
    Article
  14. 14
    The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR Center.

    The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier St... by Dong Xu, Yong Hou, Yuanfang Zheng, Yue Zheng, Mengtao Li, Xiaofeng Zeng

    Published 2016-01-01
    Get full text
    Article
  15. 15
    LSO-009 The impact of high-risk antiphospholipid antibodies profile on major organ damage progression in systemic lupus erythematosus: CSTAR multiple prospective cohort study

    LSO-009 The impact of high-risk antiphospholipid antibodies profile on major organ damage progression in systemic lupus erythematosus: CSTAR multiple prospective cohort study by Xiaofeng Zeng, Qian Wang, Jiuliang Zhao, Xinping Tian, Mengtao Li, Yufang Ding

    Published 2023-07-01
    Article
  16. 16
    LP-188 Glucocorticoids withdrawn in systemic lupus erythematosus patients with serologically active clinically quiescent state: a desirable goal

    LP-188 Glucocorticoids withdrawn in systemic lupus erythematosus patients with serologically active clinically quiescent state: a desirable goal by Xiaofeng Zeng, Qian Wang, Jiuliang Zhao, Xinping Tian, Mengtao Li, Yufang Ding

    Published 2023-07-01
    Article
  17. 17
    Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population

    Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population by Chaojun Hu, Chaojun Hu, Xi Li, Xi Li, Jiuliang Zhao, Jiuliang Zhao, Qian Wang, Qian Wang, Mengtao Li, Mengtao Li, Xinping Tian, Xinping Tian, Xiaofeng Zeng, Xiaofeng Zeng

    Published 2020-10-01
    Get full text
    Article
  18. 18
    Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis

    Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis by Nan Jiang, Nan Jiang, Nan Jiang, Nan Jiang, Shangyi Jin, Shangyi Jin, Shangyi Jin, Shangyi Jin, Chen Yu, Chen Yu, Chen Yu, Chen Yu, Jiuliang Zhao, Jiuliang Zhao, Jiuliang Zhao, Jiuliang Zhao, Qian Wang, Qian Wang, Qian Wang, Qian Wang, Xinping Tian, Xinping Tian, Xinping Tian, Xinping Tian, Mengtao Li, Mengtao Li, Mengtao Li, Mengtao Li, Xiaofeng Zeng, Xiaofeng Zeng, Xiaofeng Zeng, Xiaofeng Zeng

    Published 2023-10-01
    Get full text
    Article
  19. 19
    Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody

    Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody by Xin Sun, Min Peng, Ting Zhang, Zongru Li, Lan Song, Mengtao Li, Juhong Shi

    Published 2021-03-01
    Get full text
    Article
  20. 20
    A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus

    A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus by Shuo Zhang, Nan Jiang, Li Wang, Li Zhang, Hua Chen, Mengtao Li, Xiaofeng Zeng

    Published 2021-10-01
    Get full text
    Article

Search Tools: